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ABSTRACT 
Two simple and sensitive visible spectrophotometric methods are described for the determination of tianeptine in 
bulk and pharmaceutical preparations based on the formation of colored species with SA- NaNO2- Į- NA (M1) or 
SNP-acetaldehyde reagent (M2) under specified experimental conditions and exhibiting Ȝ max at 479 nm or 555nm 
respectively. The Regression analysis of Beer’s Law plot showed good correlation in a general concentration range 
of 10-30µg/ml or 8.0-24µg/ml with correlation coefficient (r2=0.999) for methods M1 and  M2 respectively. The 
proposed methods are applied to commercial available stablon tablets and the results are statistically compared with 
those obtained by the UV reference method and validated with respect to accuracy, precision, linearity, limit of 
detection, percentage of recovery, repeatability and recovery studies. The results are found satisfactory and 
reproducible. These methods are applied successfully for the estimation of tianeptine in tablet form without the 
interference of excipients.  
 Key words: Assay; Acetaldehyde; Coupling; Diazotization; Regression equation; Sodium nitroprusside. 
 
INTRODUCTION 
Tianeptine sodium (TIA) (Figure 1) is a tricyclic antidepressant compound of dibenzothiazepine type and   neuro 
protective, anxiolytic and mood-brightening serotonin reuptake enhancer. TIA, designated (RS)-7-[(3-chloro-6, 11-
dihydro-6-methyl dibenzo [c, f] [1, 2] thiazepin-11-yl) amino] heptanoic acid S,S-dioxide mono sodium salt1 and 
has the molecular formula of C21H24ClN2O4SNa. Its molecular weight is 458.93. The drug exists as two isomers, of 
which the leavo isomer seems to be the therapeutically active form and shows serotonergic activity by enhancing the 
presynaptic reuptake of serotonin. The drug is official in European Pharmacopoeia 2 and suggests potentiometric 
titration method for the determination of TIA in bulk and tablet formulations. The drug is mainly metabolized by the 
external route; ȕ-oxidation of its heptanoic side chain is the major metabolic pathway and the pentanoic (MC5) and 
propionic (MC3) acid side chain derivatives are the major metabolites in urine and plasma, inhibits the 
mitochondrial oxidation of medium and short chain fatty acids in mice, further displaying therapeutic activity. 
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Figure 1: Chemical structure of Tianeptine sodium 
In the literature, several analytical techniques like HPLC3-7, PIF methods including Flow Injection analysis8, 
Spectrofluorometric9, Voltametric10, GC11, UV12 and visible spectrophotometric 13 methods have been reported for 
its determination in biological fluids and formulations. The main purpose of the present study was to establish a 
relatively simple, sensitive and validated visible spectrophotometric methods for the determination of TIA in pure 
form and in pharmaceutical dosage forms, since most of the previous methods involve sophisticated equipments 
which are costly and pose problems of maintenance. Hence they are not in the reach of most laboratories and small 
scale industries. So the authors have made some attempts in this direction and succeeded in developing two methods 
using SA- NaNO2- Į- NA14 or SNP-ACD15 reagents based on the formation of colored species. These methods can 
be extended for the routine quality control analysis of pharmaceutical products containing TIA. 
MATERIALS & METHODS (EXPERIMENTAL) 
Apparatus and chemicals  
       A Milton Roy UV/Visible spectrophotometer model-1201 with 10mm matched quartz cells was used for all 
spectral measurements.  Systronics model-362 pH meter was used for all the pH measurements.  STABLON Tablets 
purchased from local market. All the chemicals used were of analytical grade. Sulphanilamide (SD-fine, 0.5%, 
7.25x10-2M prepared by dissolving 500mg of SA in 25ml of acetone), NaNO2 (E.Merck,2%, 0.29M prepared by 
dissolving 2.0g of sodium nitrite in 100ml distilled water), Į-Naphthyl Amine (BDH, 0.2% 1.40x10-2M prepared by 
dissolving 200mg of Į-NA in 100ml methanol), Aqueous solutions of sodium nitroprusside (SNP, E. Merck, 1.0%, 
3.35x10-2M), acetaldehyde (10%), phosphate buffer of pH 8.0(prepared by mixing 30ml of 0.067M potassium 
hydrogen phosphate and 970ml of 0.067Mdisodium hydrogen phosphate and pH adjusted to 8.0) were prepared for 
method M1 and M2.  
Preparation of Standard stock solution:  
The standard stock solution (1mg/ml) of TIA was prepared by dissolving 100mg of TIA initially in 10ml of 0.1M 
NaOH and followed by dilution to 100 ml with distilled water. The working standard solution of TIA 100 µgml-1 
(M1) or 200µgml-1 (M2) was obtained by appropriately diluting the standard stock solution with the same solvent. 
The prepared stock solution was stored at 4϶ C protected from light. From this stock solution, a series of standards 
were freshly prepared during the analysis day. 
Preparation of Sample solution:  About 20 tablets were weighed to get the average tablet weight and pulverized. 
The powder equivalent to 100mg of TIA was weighed, dispersed in 25ml of isopropyl alcohol, sonicated for 15 
minutes and filtered through Whatman filter paper No 41.The filtrate was evaporated to dryness and the residue was 
dissolved as under standard solution preparation.  
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Analytical procedures: 
Preparation of calibration graphs: 
Method M1: Aliquots (1.0ml-3.0ml, 100µgml-1) of the standard TIA solution were transferred into a series of 10ml 
calibrated tubes. To this 0.1ml each of sulphanilamide, sodium nitrite, Į-napthyl amine solutions were added 
successively. Then total volume was brought to 5ml with distilled water and heated for 5 min at 70ºc. After 
immersing the tube in water bath at 20ºc for 2 min, 2ml of ethanol was added and the volume in the calibrated tube 
was made up to the mark with distilled water. The absorbance of the colored azo dye solutions were measured after 
5 min at 479nm against a reagent blank prepared similarly. The content of the drug was computed from the 
calibration graph (Figure 2).  
 
Figure 2: Beer’s Law plot of TIA-SA-NaNO2-NA system 
Method M2: Aliquots of working standard TIA drug solution (200µgml-1) such as 1.0, 1.5, 2.0 2.5 and 3.0 ml were 
taken separately  in  a  series  of  25ml  calibrated  tubes  containing  15ml  of  buffer  pH 8.0.  Then 1.0ml  each of  SNP 
solution and acetaldehyde were added successively and shaken for 2 minutes and kept aside for 5 minutes at room 
temperature and made up to the mark with distilled water and sonicated for 1 min for complete color development. 
The purple colored species was obtained and it was stable for 1 hour.  The absorbance of the colored species was 
measured  at  555  nm  against  the  reagent  blank.  The  calibration  graph  was  constructed  by  plotting  the  drug  
concentration versus absorbance. The amount of drug was computed from its calibration curve (Figure 3).  
 
Figure 3: Beer’s Law plot of TIA-SNP-ACD system 
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RESULTS AND DISCUSSION 
In developing these methods, systematic studies of the effects of various parameters were undertaken by varying one 
parameter at a time and controlling all others fixed (OVAT method). The effect of various parameters such as time, 
temperature, nature and concentration of reagents, volume and strength of reagents and order of addition of reagents 
on color development and solvent for final dilution on the intensity and stability of the colored species were studied 
and the optimum conditions were established. Other water miscible solvents like methanol, ethanol, propan-2-ol and 
acetonitrile were found to provide no additional advantage. So distilled water is selected as a solvent for final 
dilution of the colored species for both methods. The optical characteristics such as Beer’s law limit, Sandell‘s 
sensitivity, molar absorptivity, percent relative standard deviation (calculated from the six measurements containing 
3/4th of the amount of the upper Beer’s law limits), Regression characteristics like standard deviation of slope (Sb), 
standard deviation of intercept (Sa), standard error of estimation (Se) and % range of error (0.05 and 0.01 confidence 
limits) were calculated using MS Excel software-2007and are shown in TABLE 1. 
       Commercial formulations containing TIA were successfully analyzed by the proposed method. The values 
obtained by the proposed and reference method (reported UV method in methanol, Ȝ max 220nm) for formulations 
were compared statistically by the t-and F-test and found not to differ significantly. As an additional demonstration 
of accuracy, recovery experiments were performed by adding a fixed amount of the drug to the pre analyzed 
formulations at three different concentration levels. These results are summarized in TABLE 2. Chemistry of 
colored species:   
Method M1: Alkanols are generally determined by converting them into alkyl nitrites. The latter upon hydrolysis 
liberates nitrous acid stoichiometrically. The liberated nitrous acid is used for diazotizing a primary aryl amine (SA). 
The diazo compound so produced is coupled to an amine (NA) in the usual manner to yield a dye. In the present 
investigation, the free carboxyl group present in the drug is involved for the release of nitrous acid from NaNO2. The 
former diazotizes SA, which is turn coupled with Į-napthylamine to give a colored azo dye (Figure 4 showing 
Scheme). 
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Figure 4: Probable Scheme for method M1 
Method M2: Cullies and Waddington 16 found that many secondary but not primary or tertiary amines react with 
sodium nitroprusside and acetaldehyde under mild alkaline conditions. Wolfe and Swine hart 17 have reported the 
formation of [Fe (CN) 5 H2O] 3- in aqueous solution of sodium nitroprusside. The proposed method M2 exploits 
structural features aliphatic secondary amine of the TIA molecule. The nature of colored species formation with 
sodium nitroprusside-acetaldehyde reagent is initial N-alkyl vinyl amine formation with acetaldehyde then followed 
by formation of colored inner molecular complex with sodium nitroprusside has been assumed in the scheme. Based 
on the analogy, the probable sequence of reactions is presented in scheme (Figure 5). 
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Figure 5: Probable Scheme for method M2 
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TABLE 1: optical characteristics, precision and accuracy of proposed methods 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parameter Method M1 Method M2 
ʢmax 479 555 
Beer’s law limit(µg/ml) 10-30 8-24 
Sandell’s   sensitivity 
(µg/cm2/0.001 abs. unit 
0.008888889 0.002895928 
Molar absorptivity 
(Litre/mole/cm) 51744.7125 158827.5203 
 
Correlation coefficient 
Regression equation         
(Y)*  
0.999 0.999 
Intercept (a) -0.091 -0.099 
 Slope(b) 0.016 0.020 
                                  
%RSD 1.82 1.92 
% Range of errors (95% 
Confidence  limits) 
0.05 significance level 
0.01 significance level 
  
1.91 2.0 
3.0 3.2 
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    *Y = a + b x, where Y is the absorbance and x is the concentration of TIA in µg/ml 
 
 
 
 
 
 
 
 
TABLE 2: Analysis of tianeptine sodium in pharmaceutical formulations by proposed and reference methods. 
Method *Formulations Labeled 
Amount 
(mg) 
Found by Proposed Methods Found by 
Reference 
Method  ± 
SD 
#% Recovery 
by Proposed 
Method ± SD 
**Amount 
found ± 
SD 
t F 
M1 STABLON 
TABLETS 
12.5 12.15± 
0.30 
0.86 3.3 12.03± 
0.17 
97.22 ±  2.43 
       
M2 STABLON 
TABLETS 
12.5 12.13 ± 
0.35 
0.58 4.3 12.03± 
0.17 
 
97.07 ± 2.79 
       
* Stablon tablets of Serdia Pharmaceuticals (India) Pvt. Ltd. 
**Average ± Standard deviation of six determinations, the t- and f-values refer to comparison of the proposed 
method with reference method. (UV). Theoretical values at 95% confidence limits t =2.57 and f = 5.05.  
# Recovery of 10mg added to the pre-analyzed sample (average of three determinations).  
 Reference method (UV method) using methanol (Ȝ max=220 nm). 
 
CONCLUSIONS 
 The procedure does not involve any critical reaction conditions or tedious sample preparation. The proposed 
analytical methods are validated as per ICH guide lines and possess reasonable precision, accuracy. These methods 
offer the advantages of rapidity, simplicity, sensitivity and can be used as alternative methods to the reported ones 
for the routine determination of TIA depending on the need and situation. 
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